As the post-pandemic world of work continues to evolve, so do recruiters’ strategies and tools for finding and engaging top talent. In 2023, we are seeing these seven trends:1. Employer branding is becoming an increasingly important factor in the recruitment…
HOME > TOP STORIES
TOP STORIES
-
REGULATORY MHLW Study Group Postpones Decision on Relief System for Victims of Health Damages Due to Anticancer Drugs
November 21, 2011
-
REGULATORY After Delay, CSIMC Recommends Listing of Ilaris for Treatment of CAPS
November 21, 2011
-
ORGANIZATION 6 Indian Generics Companies Including Zydus Form Association, to Start Operations This Month
November 18, 2011
-
BUSINESS Teva to Merge Taiyo, Kowa-Teva, Establish “Teva Pharma Japan” in Mid-2012
November 18, 2011
-
BUSINESS Fujifilm, Kyowa Kirin to Set Up Joint Venture for Biosimilars in 2012
November 17, 2011
-
REGULATORY CSIMC Recommends Listing of 9 Products Including Imusera; Recommendation Put on Hold for Ilaris
November 17, 2011
-
REGULATORY High Court Turns Down Iressa Compensation Appeal
November 16, 2011
-
REGULATORY 7-Drug Rule Should Be Relaxed or Eliminated to Promote GE Name Prescribing: Dr Adachi of CSIMC
November 16, 2011
-
BUSINESS Japan’s Jul-Sep 2011 Ethical Drug Market Grows 7.7%: IMS Japan
November 15, 2011
-
BUSINESS Otsuka Forms Alliance with Lundbeck in CNS Field
November 14, 2011
-
BUSINESS Top-3 GE Makers Report 10.4% Increase in Sales; Pace Down from Year Before
November 11, 2011
-
REGULATORY MHLW Proposes Raising GE Dispensing Rates to Receive Upper Premiums for GE Dispensing Systems
November 10, 2011
-
REGULATORY Applications for “Regulatory Strategy Consultation” Increasing Rapidly: Mr Isobe of PMDA
November 10, 2011
-
BUSINESS Operating Profit Rate for Top-4 Wholesalers Slips to 0.39% in April-September
November 9, 2011
-
BUSINESS Astellas, RIKEN to Explore, Jointly Develop Novel Drug Targets for AD
November 9, 2011
-
BUSINESS Towa Pharmaceutical Developing Lipitor Generic Version OD Tablets
November 9, 2011
-
BUSINESS Towa Pharmaceutical’s New Business Plan is “Groundwork for Future Progress”
November 8, 2011
-
BUSINESS Suzuken President Ota Says Wholesale Business Recovery Crucial
November 8, 2011
-
BUSINESS 8 of 10 Leading Drug Makers Report Declines in 1st-Half Sales
November 7, 2011
-
REGULATORY CSIMC Subcommittee Approves Proposal to Expand Range of Drugs Subject to Re-pricing
November 4, 2011
ページ
Novo Nordisk’s weight-loss medication Wegovy (semaglutide) was approved in Japan in March. While it skipped the May round of reimbursement listing, physicians eagerly await the arrival of what would be the first new obesity drug in three decades. Other companies…
Japan’s health ministry on April 27 presented an outline of a report to be compiled next month by its key…
A key Japanese reimbursement policy panel on December 16 approved the government-backed plan for the FY2023 “off-year” drug price revision.…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…